Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of QLM3004 atropine eye drops at different concentrations to delay myopia progression in children
CTR20232314Phase 3Active
- Sponsor
- Qilu Pharmaceutical
- Start
- Aug 2023
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atropine in myopia, sponsored by Qilu Pharmaceutical. Started Aug 2023; status: active.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on CTR20232314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232314.